Danaher Corp (DHR)
275.44
-1.49
(-0.54%)
USD |
NYSE |
Sep 27, 16:00
275.48
+0.04
(+0.01%)
After-Hours: 20:00
Danaher Research and Development Expense (Annual): 1.503B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.503B |
| December 31, 2022 | 1.528B |
| December 31, 2021 | 1.498B |
| December 31, 2020 | 1.348B |
| December 31, 2019 | 1.126B |
| December 31, 2018 | 1.059B |
| December 31, 2017 | 956.40M |
| December 31, 2016 | 975.10M |
| December 31, 2015 | 861.40M |
| December 31, 2014 | 769.40M |
| Date | Value |
|---|---|
| December 31, 2013 | 1.104B |
| December 31, 2012 | 1.138B |
| December 31, 2011 | 1.018B |
| December 31, 2010 | 774.00M |
| December 31, 2009 | 632.65M |
| December 31, 2008 | 725.44M |
| December 31, 2007 | 601.42M |
| December 31, 2006 | 440.00M |
| December 31, 2005 | 374.31M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
1.126B
Minimum
2019
1.528B
Maximum
2022
1.401B
Average
1.498B
Median
2021
Research and Development Expense (Annual) Benchmarks
| Quest Diagnostics Inc | -- |
| Exact Sciences Corp | 425.88M |
| Illumina Inc | 1.354B |
| Natera Inc | 320.68M |
| Castle Biosciences Inc | 53.62M |